(Sandhya Jha, Intern Journalist): The World Health Organization (WHO) has currently stopped a trial of hydroxychloroquine for the treatment of corona. This decision was taken in view of the side effects of this medicine. A study in the medical journal Lancet said last week that giving hydroxychloroquine to Corona patients could increase their risk of death, according to WHO Chief Tedross Adhanom Ghebreyesus.
Trials released other than hydroxychloroquine
Ghebreyyesus said on Monday that hundreds of hospitals around the world have stopped giving hydroxychloroquine as a precaution to Corona patients. Apart from this, other trials are going on. The Data Safety Monitoring Board is reviewing the data.
US President himself said to take hydroxychloroquine
Hydroxychloroquine is usually given to patients with arthritis, but many countries believe that the drug is also helpful in preventing corona. US President Donald Trump said last week that he himself was taking hydroxychloroquine. After this, many countries started buying this medicine in bulk. The Brazilian Ministry of Health has also recommended hydroxychloroquine and the malaria drug chloroquine to patients with mild symptoms of the corona.
Research claims- hydroxychloroquine does not benefit corona patients
On the other hand, the Lancet study said that both drugs can have serious side effects. Heartbeat, in particular, can be abnormal (abnormal). Corona patients do not benefit from these drugs. This was claimed in the Lancet study based on the records of 96 thousand patients admitted to hundreds of hospitals.